Cited by 38Advanced Glycation End Products researchDiabetes Management and ResearchSkin Diseases and Diabetes

Skin Autofluorescence – A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes

Open access
Stirban, Alin, Heinemann, Lutz, Director Endocrinology and Diabetes Complications, Senior Scientific Consultant, Profil, Neuss, Germany·2014·European Endocrinology

Abstract

The results of the Diabetes Control and Complications Trial-Epidemiology of Diabetes Interventions and Complications (DCCT-EDIC) study have strengthened the ‘glycaemic memory’ concept, postulating that the quality of metabolic control over several years predicts the development of diabetic complications. To mirror long-term metabolic control, the degree of glycated haemoglobin (HbA 1c ) might not represent the optimal biomarker. Other substances with a longer persistence, like the so-called advanced glycation end-products (AGEs), which probably form the substrate of the glycaemic memory, might perform better. Newly developed methods such as the assessment of skin autofluorescence (SAF), enable fast, uncomplicated and non-invasive AGEs assessment. SAF was validated for diabetes screening and shows a good predictive value for the development of diabetic and cardiovascular complications. This article deals with the theoretical background and with available clinical data on this new variable.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.17925/ee.2014.10.02.106

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Skin AF measurement correlates well with total amount of AGEs in skin biopsies.

    “The measurement correlates well with the total amount of AGEs in skin biopsies”

    From Protein oxidation - Formation mechanisms, detection and relevance as biomarkers in human diseases (2021) · cites this paper as [161]

    The section on skin autofluorescence as a surrogate for AGE accumulation says SAF measurements were validated against biochemical analyses of skin biopsies. However, the Measurement of the Skin Autofluorescence section explains that some AGEs do not fluoresce and that other substances also contribute to autofluorescence. The paper supports SAF as a surrogate for skin AGE accumulation, but does not establish that it correlates well with the total amount of AGEs in biopsies. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Skin AF has been applied in clinical settings, indicating elevated AGE levels in several diseases and aging.

    “has been applied in clinical settings, indicating elevated AGE levels in several diseases and aging, as shown in Table 5”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Vlassara H, Striker G, The role of AGE-products in the etiology of insulin resistance and diabetes, US Endocrinology, 2010;6:14-9.

Cited by

Sorted by citations

Authors
Stirban, A., Heinemann, L., Complications, D. E. A. D., & Senior Scientific Consultant, P.
Corresponding author
Stirban, Alin
Venue
European Endocrinology
Published
2014
Volume
10
Issue
2
Pages
106
ISSN
1758-3772 (ISSN-L)
OpenAlex
W2494719080
Cited by
38
References
70
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 6 · 2021: 10 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 1 · 2015: 1
FWCI
0.08
Type
journal article
Language
en
Open access
Locations
  • touchREVIEWS in Endocrinology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
Keywords
skin autofluorescence, advanced glycation end products, cardiovascular risk, diabetes risk, non-invasive biomarkers, long-term glycemic control, diabetes complications, diabetes screening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review